Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

New formulation of salmon calcitonin undergoes U.S. phase I trial

Aug. 9, 1996

No Comments

Duphar reports Vitamin D compounds with multiple therapeutic activity

Aug. 9, 1996

No Comments

Comparative study results of Systen and Menorest

July 26, 1996

No Comments

Prostaglandin E1 regimen shows positive results for male erectile dysfunction

July 26, 1996

No Comments

ALT-766: New AGE cross-link breaker from Alteon

July 26, 1996

No Comments

Phase III results indicate Ergoset's effectiveness and safety

July 26, 1996

No Comments

Selective beta3-adrenoceptor agonists in Dainippon's pipeline

July 26, 1996

No Comments

Ibex licenses technology from Centre for Applied Microbiology and Research

July 26, 1996

No Comments

Celtrix's SomatoKine proven safe in phase I

July 26, 1996

No Comments

SR-12813: SmithKline Beecham and Symphar's hypocholesterolemic drug

July 26, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Endocrine/metabolic
RSS

New formulation of salmon calcitonin undergoes U.S. phase I trial

Duphar reports Vitamin D compounds with multiple therapeutic activity

Comparative study results of Systen and Menorest

Prostaglandin E1 regimen shows positive results for male erectile dysfunction

ALT-766: New AGE cross-link breaker from Alteon

Phase III results indicate Ergoset's effectiveness and safety

Selective beta3-adrenoceptor agonists in Dainippon's pipeline

Ibex licenses technology from Centre for Applied Microbiology and Research

Celtrix's SomatoKine proven safe in phase I

SR-12813: SmithKline Beecham and Symphar's hypocholesterolemic drug

Today's news in brief

Today's news in brief

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Australia’s Celosia heads toward clinic with gene therapy for ALS

Sangamo stock plunges as Pfizer leaves hemophilia partnership

Endocrine/metabolic RSS

Endocrine/metabolic
RSS